Wanna Beat the Market? Try These 2 Tech Stocks That Look Undervalued Today

Here’s why undervalued TSX stocks such as Vitalhub can help you generate outsized gains in the next 12 months.

| More on:
A worker uses the cloud for paperless work. tech

Source: Getty Images

Investing in undervalued stocks is a popular strategy as it helps you beat broader market returns over time. You need to identify quality companies that currently trade below their intrinsic value and benefit from outsized gains when market sentiment improves.

Here are two such undervalued TSX tech stocks you can consider buying today.

Vitalhub stock

Valued at $255 million by market cap, Vitalhub (TSX:VHI) is a health-tech company that provides solutions in Canada, the U.S., the U.K., Australia, and Asia. Its solutions include electronic healthcare records, case management, and patient flow, among others.

Vitalhub has almost tripled sales from $13.79 million in 2020 to $40 million in 2022. Unlike several other growth stocks, the company generates consistent profits, reporting an operating income of $35 million in the last four quarters.

Vitalhub recently announced the acquisition of BookWise Solutions for roughly $4 million. BookWise provides scheduling software for healthcare companies ranging from general room booking solutions to specialist scheduling systems. Its suite of products should allow enterprises to easily manage resources and improve operational efficiencies. BookWise ended 2023 with more than 150 customers and sales of $1.5 million, 50% of which is recurring in nature.

VitalHub reported strong double-digit year-over-year growth across business segments such as term licenses, maintenance and support, perpetual licenses, and services. Its business continues to grow organically as well as via acquisitions, allowing it to increase annual recurring revenue by 38% year over year to $42.6 million. The company grew 17% of its top line organically, while the rest was derived from acquisitions.

Vitalhub ended the third quarter (Q3) with almost $30 million in cash, providing it with enough room to navigate an uncertain macro environment. Analysts tracking the TSX stock expect sales to rise to $60 million in 2024, while adjusted earnings are forecast at $0.17 per share. Priced at 34 times forward earnings, VitalHub stock is not too expensive, given its stellar growth estimates.

Sylogist stock

An enterprise-facing software company, Sylogist (TSX:SYZ), provides SaaS (software-as-a-service) solutions to clients in Canada, the U.S., and the United Kingdom. Valued at $212 million by market cap, it manages IT services, network security, and web portals.

In Q3 of 2023, Sylogist reported revenue of $16.8 million, an increase of 18% year over year. Its SaaS ARR (annual recurring revenue) growth stood at 26 years over year, while recurring revenue grew by 12%.

With a gross margin of 61%, Sylogist reported an adjusted EBITDA of 26% or $4.4 million in the September quarter. It ended Q3 with a backlog of $32.2 million, providing investors with enough revenue visibility.

Due to its consistent profit margins, Sylogist pays shareholders an annual dividend of $0.04 per share, translating to a forward yield of 0.44%.

Analysts tracking SYZ stock expect sales to rise from $66 million in 2023 to $73 million in 2024. Its adjusted earnings per share are forecasted to expand from $0.07 per share to $0.26 per share in this period.

Priced at 34 times 2024 earnings, SYZ stock might seem expensive. But analysts remain bullish and expect the TSX tech stock to surge 30% in the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Sylogist and Vitalhub. The Motley Fool has a disclosure policy.

More on Tech Stocks

falling red arrow and lifting
Tech Stocks

Is Shopify a Buy, Sell, or Hold?

Shopify (TSX:SHOP) stock has been pulling back of late, opening up a window for dip buyers.

Read more »

Different industries to invest in
Tech Stocks

2 No-Brainer Growth Stocks to Buy Now With $2,000 and Hold Long Term

These growth stocks have already proven their worth this year, but are solid investments for long-term holders as well.

Read more »

woman data analyze
Tech Stocks

1 Stock That’s Just as Hot as Nvidia (Without All the Hype)

Nvidia (NASDAQ:NVDA) stock has surged in share price, but so has this stock, with a far lower share price to…

Read more »

Index funds
Tech Stocks

Constellation Software Stock: Buy, Sell, or Hold?

Unveiling the Code: Should you Buy, Hold, or Sell Constellation Software (TSX:CSU) stock at current levels?

Read more »

A plant grows from coins.
Tech Stocks

Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now

Growth investors should have these two tech stocks high up on their watch lists.

Read more »

Hand writing Time for Action concept with red marker on transparent wipe board.
Tech Stocks

Well Health Stock Is Down 58% From its Highs – Time to Buy?

Well Health stock has been hit, but the company remains on a path of record-breaking revenues as it approaches positive…

Read more »

Business man on stock market financial trade indicator background.
Tech Stocks

TFSA: The Most Expensive Stock in Canada Is a Top Buy Today

CSU stock (TSX:CSU) may be the priciest stock on the TSX today, but there is a very good reason for…

Read more »

TFSA and coins
Dividend Stocks

TFSA: Invest $15,000 in CSU Stock and Get $4,694 in Passive Income

CSU stock (TSX:CSU) has surged in the last year, yet even if growth slows by half, you could create immense…

Read more »